Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Bourgeois, Marc Louis
1999.
Manage or Perish?.
p.
317.
Martin, Ian L
and
Lattmann, Eric
1999.
Benzodiazepine recognition site ligands and GABAAreceptors.
Expert Opinion on Therapeutic Patents,
Vol. 9,
Issue. 10,
p.
1347.
Neugebauer, R
1999.
Mind matters: the importance of mental disorders in public health's 21st century mission..
American Journal of Public Health,
Vol. 89,
Issue. 9,
p.
1309.
Wang, Philip S.
Berglund, Patricia
and
Kessler, Ronald C.
2000.
Recent care of common mental disorders in the united states.
Journal of General Internal Medicine,
Vol. 15,
Issue. 5,
p.
284.
Bowen, RC
Senthilselvan, A
and
Barale, A
2000.
Physical Illness as an Outcome of Chronic Anxiety Disorders.
The Canadian Journal of Psychiatry,
Vol. 45,
Issue. 5,
p.
459.
Knapp, Martin
2000.
Schizophrenia costs and treatment cost‐effectiveness.
Acta Psychiatrica Scandinavica,
Vol. 102,
Issue. s407,
p.
15.
Lindström, Eva
and
Bingefors, Kerstin
2000.
Patient Compliance with Drug Therapy in Schizophrenia.
PharmacoEconomics,
Vol. 18,
Issue. 2,
p.
105.
Davies, B
2000.
V. THE STIGMA OF ANXIETY DISORDERS.
International Journal of Clinical Practice,
Vol. 54,
Issue. 1,
p.
44.
Wittchen, H.-U.
2001.
International Encyclopedia of the Social & Behavioral Sciences.
p.
9654.
Pincus, Harold Alan
Pechura, Constance M.
Elinson, Lynn
and
Pettit, Amy R.
2001.
Depression in primary care: linking clinical and systems strategies.
General Hospital Psychiatry,
Vol. 23,
Issue. 6,
p.
311.
Hodgkinson, Kathleen A
Murphy, Jillian
O'Neill, Sheri
Brzustowicz, Linda
and
Bassett, Anne S
2001.
Genetic Counselling for Schizophrenia in the Era of Molecular Genetics.
The Canadian Journal of Psychiatry,
Vol. 46,
Issue. 2,
p.
123.
Wan, GJ
Crown, WH
Berndt, ER
Finkelstein, SN
and
Ling, D
2002.
HEALTHCARE EXPENDITURE IN PATIENTS TREATED WITH VENLAFAXINE OR SELECTIVE SEROTONIN REUPTAKE INHIBITORS FOR DEPRESSION AND ANXIETY.
International Journal of Clinical Practice,
Vol. 56,
Issue. 6,
p.
434.
Percudani, Mauro
Fattore, Giovanni
Belloni, Gian Carlo
Gerzeli, Simone
and
Contini, Agostino
2002.
Service utilisation and costs of first-contact patients in a community psychiatric service in Italy.
European Psychiatry,
Vol. 17,
Issue. 8,
p.
434.
Jacobi, Frank
Wittchen, Hans‐Ulrich
Hölting, Christoph
Sommer, Sieghard
Lieb, Roselind
Höfler, Michael
and
Pfister, Hildegard
2002.
Estimating the prevalence of mental and somatic disorders in the community: aims and methods of the German National Health Interview and Examination Survey.
International Journal of Methods in Psychiatric Research,
Vol. 11,
Issue. 1,
p.
1.
2002.
ECNP Consensus Meeting March 2000.
European Neuropsychopharmacology,
Vol. 12,
Issue. 1,
p.
81.
Wagner, R
Manicavasagar, Vijaya
and
Silove, Derrick
2002.
Challenges and early experiences in the development of an anxiety clinic in the public health sector.
General Hospital Psychiatry,
Vol. 24,
Issue. 6,
p.
406.
Clarke, Mary
and
O'Callaghan, Eadbhard
2003.
Is earlier better? At the beginning of schizophrenia: timing and opportunities for early intervention.
Psychiatric Clinics of North America,
Vol. 26,
Issue. 1,
p.
65.
2003.
Australian and New Zealand Clinical Practice Guidelines for the Treatment of Panic Disorder and Agoraphobia.
Australian & New Zealand Journal of Psychiatry,
Vol. 37,
Issue. 6,
p.
641.
Carr, Vaughan J.
Neil, Amanda L.
Halpin, Sean A.
Holmes, Scott
and
Lewin, Terry J.
2003.
Costs of Schizophrenia and Other Psychoses in Urban Australia: Findings from the Low Prevalence (Psychotic) Disorders Study.
Australian & New Zealand Journal of Psychiatry,
Vol. 37,
Issue. 1,
p.
31.
von Moltke, Lisa L.
and
Greenblatt, David J.
2003.
Medication dependence and anxiety.
Dialogues in Clinical Neuroscience,
Vol. 5,
Issue. 3,
p.
237.
eLetters
No eLetters have been published for this article.